Concepedia
Statistics
Publications
3
Citations
157
H-Index
Active since
2017
Affiliations
University of Cologne(Current)
University Hospital Cologne
Cologne Excellence Cluster on Cellular Stress Responses in Aging Associated Diseases
Heidelberg University
Integrated Oncology (United States)
Tim Rehkämper is an author at University of Cologne specializing in molecular oncology, oncology, and cancer genetics.
Publications per year
2017–2020
Targeting a non-oncogene addiction to the ATR/CHK1 axis for the treatment of small cell lung cancer
Fabian Doerr, Julie George, Anna Schmitt et al. · Scientific Reports · 2017 · 64 citations · Full text
Medicine, Oncology, Pharmacology +17
Two mouse models reveal an actionable PARP1 dependence in aggressive chronic lymphocytic leukemia
Gero Knittel, Tim Rehkämper, Darya Korovkina et al. · Nature Communications · 2017 · 55 citations · Full text
Medicine, Molecular Genetics, Oncology +17
An Autochthonous Mouse Model of <i>Myd88</i> - and <i>BCL2</i> -Driven Diffuse Large B-cell Lymphoma Reveals Actionable Molecular Vulnerabilities
Ruth Flümann, Tim Rehkämper, Pascal Nieper et al. · Blood Cancer Discovery · 2020 · 38 citations · Full text
Life Sciences, Molecular Biology, Oncology +16
1–3 of 3